this is an outdated text: switch to the updated & improved dc code website
home, about

The DC Code: § 3-1207.41 Scope of practice.

Index3 District of Columbia Boards and Commissions. (Refs & Annos)
a
An individual shall be licensed by the Board of Pharmacy before engaging in the practice of pharmaceutical detailing in the District of Columbia.
b
A pharmaceutical detailer shall not:
1
Engage in any deceptive or misleading marketing of a pharmaceutical product, including the knowing concealment, suppression, omission, misleading representation, or misstatement of any material fact;
2
Use a title or designation that might lead a licensed health professional, or an employee or representative of a licensed health professional, to believe that the pharmaceutical detailer is licensed to practice medicine, nursing, dentistry, optometry, pharmacy, or other similar health occupation, in the District of Columbia, unless the pharmaceutical detailer currently holds such a license; or
3
Attend patient examinations without the consent of the patient.

Historical and Statutory

Legislative History of Laws Law 17-131, the "SafeRx Amendment Act of 2008", was introduced in Council and assigned Bill No. 17-364 which was referred to the Committee on Health. The Bill was adopted on first and second readings on December 11, 2007, and January 8, 2008, respectively. Signed by the Mayor on February 1, 2008, it was assigned Act No. 17-282 and transmitted to both Houses of Congress for its review. D.C. Law 17-131 became effective on March 26, 2008. Delegation of Authority Delegation of Authority pursuant to D.C. Law 17-131, the SafeRX Amendment Act of 2008, see Mayor's Order 2008-83, June 11, 2008 (55 DCR 9360). Delegation of Authority pursuant to D.C. Law 17-131, the SafeRX Amendment Act of 2008, see Mayor's Order 2008-94, July 3, 2008 (55 DCR 9375). DC CODE § 3-1207.41 Current through December 11, 2012

Credits

(Mar. 25, 1986, D.C. Law 6-99, § 741, as added Mar. 26, 2008, D.C. Law 17-131, § 102(g), 55 DCR 1659.)